If Patients Don’t Use Available Health Service Pricing Information, Is Transparency Still Important
Bibliographic Data
| ID | 15747158 |
|---|---|
| Authors | Christopher Whaley (0000-0002-9405-1989, RAND School of Public Policy, corresponding author), Austin B Frakt (0000-0002-0795-5462, Boston University) |
| Year | 2022 |
| Volume | 24 |
| Issue | 11 |
| Pages | E1056-1062 |
| Publication date | 2022-11-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | The AMA Journal of Ethic (JOURNAL) |
| Journal identifiers | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/amajethics.2022.1056 |
| PMID | 36342488 |
| OpenAlex | W4308638161 |
| Language | EN |
| Citations received | 3 |
| References cited | 4 |
The US health system is replete with health service pricing idiosyncrasies and opacity unrelated to quality. Online tools intended to make health care purchasing resemble consumerism by making prices transparent have had little if any effect on improving health care market functioning and changing patient behavior. Although price transparency is still in its infancy, it holds promise to be as useful to patient-consumers as it has been to large purchasers (eg, employers) of health services and policymakers. But even if price information is not routinely used by patients, transparency of such information still has ethical importance in a market in which patients pay increasingly high out-of-pocket costs
Business · Consumerism · Economic growth · Economics · Health care · Political science · Public economics · Purchasing · Quality (philosophy · Transparency (behavior · Global Health Care Issues · Healthcare Policy and Management · Pharmaceutical industry and healthcare · Marketing
| Citations per year | 0.75 |
|---|---|
| Citation span | 2022 - 2025 (4) |
| Highly cited | No |